Follow Us On

Facebook  X  Linkedin  YouTube
 
 

Time to Submit Comment

Letters to CMS and Congress!


CMS has issued two proposed rules that will set 2027 Medicare payment for interventional pain management: the CY 2027 Physician Fee Schedule and the CY 2027 OPPS/ASC Payment System. ASIPP is commenting on both. We ask that every State Society also file its own separate comment letter. Letters from societies across the country show CMS the nationwide impact on physicians, independent practices, ASCs, and Medicare patients.


Here are links to two sample letters:

Comment Deadline is August 31, 2026

Comment Deadline is September 14, 2026

INSTRUCTIONS FOR OPENING LETTERS

When you click on the sample letter links, the letters will automatically download to your Downloads folder.


Please use them as a starting point, not as a form.

Identical letters carry little weight with CMS. We ask you to rewrite using your own letterhead, change the wording and order, add state-specific examples, and keep ASIPP’s key issues and requests.

 

Please also write to Congress. Send letters to both of your U.S. Senators and to one member of your U.S. House delegation, asking for an annual inflation update to Medicare physician payment and relief from budget neutrality.


Click here for Senator contact information.

Click here for Representative contact information.

 

The OPPS/ASC deadline is less than one week away. Please act now.


Thank you for your continued support and advocacy on behalf of ASIPP and Medicare beneficiaries.

Discover how the Intracept™ Procedure is delivering a new standard of care for vertebrogenic pain

Join our webinar on Wednesday, September 9, at 7 pm ET, hosted in collaboration with the American Society of Interventional Pain Physicians (ASIPP), to discover how to diagnose this distinct condition and why the Intracept Procedure is a proven, purpose-built treatment option.


Robotic Phlebotomist Stand-In Gets FDA's Blessing 

Device uses infrared light and ultrasound to locate suitable veins


The FDA authorized the first robotic device that can independently draw patients' blood without a hands-on operator, the agency announced.


The Aletta device uses near-infrared light and Doppler ultrasound to locate an appropriate vein. It is authorized for use in adults in outpatient settings, under the supervision of a trained phlebotomist.


"Blood draws are one of the most commonly performed medical procedures in the United States, yet patients may face delays due to a growing shortage of trained phlebotomists," said Michelle Tarver, MD, PhD, director of the FDA's Center for Devices and Radiological Health, in the press release.


Click here to read the full article.

 

ASIPP has submitted a proposal to the Centers for Medicare & Medicaid Services (CMS) proposing the creation of an Independent Physician Payment Modifier under Medicare.


The proposal is intended to help preserve independent physician practices by establishing a modifier that would identify qualifying independent physicians and provide a 10% payment adjustment for eligible physician services, while maintaining budget neutrality and protecting existing facility payments.


Click here to view ASIPP’s Letter to Joseph Albanese, CMS/CM


Click here to view ASIPP’s Proposed Modifier for Independent Physician Services

 

CMS has released the CY 2027 Medicare Physician Fee Schedule Proposed Rule (CMS-1848-P). The overall picture is unfavorable: CMS estimates a combined -2% impact on interventional pain management, with additional proposals affecting E/M billing, MIPS, and imaging/laboratory payment. Two documents are attached — the proposed rule and ASIPP’s code-by-code payment comparison for 2027 vs. 2026. Key points below.

 

Conversion Factor: Proposed Cut

With the one-year 2.5% statutory increase for 2026 expiring, CMS proposes:

  • Qualifying APM participants: $33.17, down from $33.57 (-1.19%)
  • All other clinicians (non-QP): $32.84, down from $33.40 (-1.68%)

These figures reflect a +0.53% budget-neutrality adjustment and statutory updates of +0.75% (QP) and +0.25% (non-QP). They do not include the 2% sequester or potential 4% PAYGO cuts.

 

IPM Codes: Widespread Reductions vs. 2026

Most interventional pain codes are cut 1–6% in the office setting and 1-4% in Facility:

Office Setting

Facility Setting

Epidurals

(62321 & 62323)

-3.0% to -3.3%

-2.7% to -3.0%

Transforaminal

(64479 to 64484)

-3.7% to -4.9%

-1.2% to -3.8%

Facet joint

(64490-64495)

-1.3% to -3.5%

-1.2% to -3.6%

Radiofrequency Ablation (64633-36)

-4.9% to -5.2%

-1.2% to -3.3%

SCS Lead Placement (63650)

-5.9%

-3.0%

EM Services

(99203-205, 213-215)

1.4% to -3.8%

-1.2% to -2.5%

  • Trigeminal nerve injection (64400): -19.9%; greater occipital nerve (64405): -16.6%
  • Percutaneous SI joint fusion (27279, facility): -14.9%
  • Kyphoplasty (22513–22515): -6.0% to -6.1%
  • Spinal cord stimulator trial (63650): -5.9%; percutaneous
  • PNS (64555): -6.3%


A handful of codes see small increases (e.g., blood patch 62273, several peripheral nerve blocks). The attached table shows every IPM code.


E/M Services: Major Change to Modifier -25

CMS proposes that when a separately identifiable office E/M visit is billed with modifier -25 on the same day as a 0-, 10-, or 90-day global procedure, only the highest-paid service is paid at 100% — all others, including the E/M visit, are cut 50%. This directly targets the common office-based scenario of a same-day evaluation and injection. CMS also proposes replacing add-on code G2211 with modifier MOD1, valued at 16% of the base E/M code (32% for ACO participants via MOD2). E/M payment rates themselves decline modestly (see attached table).


MIPS / Quality Payment Program

  • Traditional MIPS would sunset with the CY 2029 performance period (2031 payment year), making MIPS Value Pathways (MVPs) the sole reporting option; three new MVPs are proposed.
  • The quality measure inventory would be set at 180 measures (20 removals, 10 additions), with a new MIPS core measure reporting requirement replacing the outcome/high-priority measure requirement (small practices exempt).
  • The performance threshold remains 75 points. Separately, the rule proposes refinements to the Ambulatory Specialty Model (ASM), the mandatory model whose low back pain cohort includes interventional pain physicians.


RFI: Duplicate Laboratory Testing, Imaging, and Interoperability

CMS is seeking input on mechanisms to address duplicate laboratory and imaging tests, including MAC edits resulting in non-payment or reduced payment, recoupment of payments, frequency limitations, and revised billing instructions, along with improved result sharing and interoperability. These policies could significantly affect pain practices that rely on imaging and drug testing. ASIPP will submit detailed comments — please send us your input.


Act Now

Comments are due September 14, 2026 (file code CMS-1848-P). Please review the attached documents and send your feedback to asipp@asipp.org so we can represent you forcefully. ASIPP will fight these cuts, as we always have — but your voice makes the difference.


View the CY 2027 PFS Proposed Rule Fact Sheet


View the ASIPP 2027 vs. 2026 Proposed Payment Rate Comparison for IPM Codes

 

SAVE THE DATE - APRIL 15-17, 2027

Save the date for the American Society of Interventional Pain Physicians' 29th Annual Meeting, April 15 - 17, 2027, in Orlando, Florida.


This flagship educational event will bring together physicians, researchers, and healthcare professionals from across the country for three days of cutting-edge education, collaboration, and professional networking.


Attendees can look forward to our most comprehensive Annual Meeting yet, featuring new educational topics, expanded faculty participation, and innovative program enhancements designed to keep you at the forefront of interventional pain management.


Mark your calendar now and plan to join us in Orlando as we continue advancing excellence in interventional pain management. Additional program details and faculty announcements will be released soon.


Register by October 1, 2026, to receive a 10% Early Bird Discount.

ASIPP is expanding opportunities for Residents and Fellows at the 2027 Annual Meeting, with more ways to present, participate, connect, and represent fellowship programs.


Present Your Research  |  Connect with Program Directors

Represent Your Program  |  Programming for Residents & Fellows


Ready to Take Your Place?

Residents and Fellows can submit an abstract to share their research at ASIPP 2027 or apply for a scholarship to help make attending the Annual Meeting possible.

Dramatic Increase in Active Surveillance Use for Prostate Cancer

Soared past 90% in VA system for low-risk disease,

to 61% for favorable intermediate-risk disease

 

Key Takeaways


• Use of active surveillance for low-risk prostate cancer rose from 27% to 93% in a study of the VA Healthcare System.


• The shift corresponded with accumulation of a strong evidence base and support of national guidelines.


• The odds for active surveillance increased with patient age and more recent diagnosis, but decreased for Black and Hispanic men.

Use of active surveillance for low- and favorable intermediate-risk prostate cancer more than tripled since 2005, according to a large study of veterans.


In 2005 active surveillance accounted for 27% of men with low-risk prostate cancer in the Veterans Affairs Healthcare System (VAHCS). By 2024 the proportion had increased to 93%. Among men with favorable intermediate-risk prostate cancer, use of active surveillance increased from 14% to 61%.


Click here to read the full article.

ASIPP is proud to launch our Resident and Fellow Mentorship Program. This initiative is designed to connect trainees with experienced pain physicians to foster professional growth, provide guidance, and strengthen the future of our specialty.


Each mentor would be paired with one to two trainees, but can take more if interested. Trainees will be responsible for initiating introductions and arranging at least one to two video calls per year. These sessions will provide opportunities for mentees to seek advice on clinical decision-making, career planning, research opportunities, and professional development.


We believe that your experience, expertise, and insight can have a lasting impact on the next generation of pain physicians. By volunteering as a mentor, you will play a critical role in shaping the future of our field and ensuring that ASIPP continues to cultivate excellence in interventional pain medicine.


If you are interested in serving as a mentor, please confirm your participation by filling out the appropriate form below.

Most Physical Activity Is Tied to Lower Dementia Risk, but This Type May Raise It

Study separates recreational exercise and work-related movement, uncovering a paradox

 

Key Takeaways


• Leisure-time exercise was associated with lower dementia risk in a large systematic review and meta-analysis.


• In contrast, occupational physical activity was associated with a higher risk of dementia.


• Physically demanding jobs may be tied to broader social and brain health risks, researchers suggested.


The relationship between physical activity and dementia risk may depend on whether the activity is recreational exercise or job-related labor, a study of more than 4.2 million people suggested.


High physical activity levels were linked to a 20% lower risk of all-cause dementia (relative risk [RR] 0.80, 95% CI 0.75-0.86) over 10 years compared with the lowest level of physical activity, reported Natan Feter, PhD, of the University of Southern California in Los Angeles, and colleagues in a systematic review and meta-analysis.


Click here to read the full article.

ASIPP is pleased to announce the launch of the Regenerative and Longevity Medicine Section!


This section reflects the growing importance of regenerative and longevity medicine—fields dedicated to restoring health, enhancing vitality, and extending the healthy years of life. From stem cell therapies and tissue engineering to gene therapy and orthobiologics, these disciplines are transforming the way we approach pain management and age-related decline.


Section membership offers:

  • Access to ASIPP’s physician database and future data registry
  • Opportunities for certification and continuing education
  • Section-exclusive resources and updates


No additional cost for ASIPP members!

Arthritis Pain Management Falls Short in U.S., CDC Study Suggests

Nearly 60% of NHIS survey respondents with arthritis report clinically significant pain

 

Key Takeaways


• Arthritis in its many manifestations is among the most common chronic conditions, affecting some 53 million adult Americans, and its associated pain often impairs the ability to perform daily activities including work.


• The Healthy People 2030 initiative set a goal of reducing the prevalence of joint pain in the U.S. to about 52%.


• In this analysis of National Health Interview Survey data from 2023, moderate to severe joint pain was reported by 58% of those with arthritis, with no change from 2019 (57%) after adjusting for age distribution.

Federal survey data for 2023 showed an estimated prevalence of moderate to severe joint pain among U.S. adults of 58.5%, suggesting that pain management in arthritis has a long way to go.


Among the participants saying they had been diagnosed with arthritis, 26.1% reported severe joint pain and another 32.4% said they had moderate pain. Adjustment for respondents' ages altered the combined estimate for moderate-to-severe pain only a little, to 58.2%, according to researchers led by Elizabeth Fallon, PhD, DrPH, of the CDC in Atlanta, using results from the National Health Interview Survey (NHIS), with some 30,000 respondents in each iteration.


Adding in respondents who reported only mild joint pain, the total prevalence of joint pain from arthritis was 75.8%, translating to 40 million American adults, the group reported in Arthritis Care & Research.


Click here to read the full article.


Apply now for one of the following 2026 dates:



October 24, November 14,

& December 12



  • ABIPP Part I

Four (4) hour virtual exam


  • ABIPP Path – Combined CCPM/ CSM Exam

For those with subspecialty in Pain Medicine

Two (2) hour virtual exam


  • ABIPP Competency Exam in IPM

For those without primary board certification

Two (2) hour virtual exam


  • ABIPP Competency Exam in Regenerative Medicine

Two (2) hour virtual exam


  • Controlled Substance Management Competency Exam

Two (2) hour virtual exam


  • Documentation, Coding, Compliance, Practice Management Competency Exam

Two (2) hour virtual exam

Exam Dates

Our Sponsor

Our Sponsor

Pain Medicine Case Reports (PMCR) and Editor-in-Chief Alaa Abd-Elsayed, MD, PhD would like to invite you to submit case reports and case series to the PMCR journal. Your article will be published free of charge.


Open access journals are freely available online for immediate worldwide open access to the full text of published articles. There is no subscription fee for open access journals. Open access journals are no different from traditional subscription-based journals: they undergo the same peer review and quality control as any other scholarly journal.


Interested in becoming a member of the PMCR Editorial Board?

Editorial board members are asked to review 2-6 manuscripts per year. Please submit your most up-to-date CV to sgold@asipp.org for consideration.


For more information or to submit your articles, click here.

We are excited to announce that Pain Medicine Case Reports (PMCR) journal (eISSN 2768-5152) has been accepted for inclusion in MEDLINE and PubMed, the prestigious bibliographic database of the U.S. National Library of Medicine. PMCR, a companion publication to the prestigious Pain Physician journal by ASIPP, joins its counterpart in achieving indexing in both MEDLINE and PubMed, marking ASIPP’s dual presence in these renowned databases.


The inclusion of PMCR journal in MEDLINE signifies a higher level of selectivity, as MEDLINE consists of the top 5,200 biomedical journals. This indexing also means that articles from PMCR will be searchable using NLM Medical Subject Headings (MeSH terms) and other metadata.


The selection for MEDLINE follows a rigorous evaluation process by reviewers from the Literature Selection Technical Review Committee (LSTRC). According to their criteria, the scientific quality of a journal’s content is the primary factor considered for indexing.


We extend our congratulations to the Pain Medicine Case Reports Editor-in-Chief, Deputy Editor-in-Chief, Journal Team, and Editorial Board for this achievement, which underscores the significance and excellence of this esteemed journal.

 

CASE REPORTS

Motor Strength Recovery Following Unilateral MILD® Procedure in a Patient With Severe Spinal Stenosis and Associated Foot Drop


Shemar Crawford, MD, Simran Prakash, MD, Caroline Jones, MD, and Ali Mostoufi, MD

Temporary Percutaneous Lateral Femoral Cutaneous Nerve Stimulation for Surgically Refractory Meralgia Paresthetica: A Case Report


Kevin Crosby, MPhil, John A. Encarnacion, MD, Andrew Aboujaoude, MD, Varun Channagiri, MD, and Mohammad H. Bawany, MD

Peripheral Nerve Stimulation of the Dorsal Scapular Nerve for Atypical Shoulder Pain Treatment: A Case Report


Breanna Lauinger, MD, Ahmed Elnahla, MD, Chineze Mbanugo, MD, Narjis Mumtaz, MD, and Roger Haddad, DO

 
 
 

RANDOMIZED CONTROLED TRIAL

Cervical Erector Spinae Plane Block vs. Epidural Steroid Injection for Cervical Radicular Pain: A Clinical Trial


Mahmoud Reza Alebouyeh, Farnad Imani, Saeid Reza Entezary, Poupak Rahimzadeh, Masood Mohseni, Sajede Salehi, Sara Saadat, and Payam Hoshyar Azar

POPULATION-BASED STUDY

Chronic Pain-Associated Mortality in the United States: A Population-Based Study, 1999-2023


Ali Al-Salahat, MBChB, Mittal Prajapati, MD, Ali Bin Abdul Jabbar, MBBS, Jyotsna Nagda, MD, Peter S. Staats, MD, and Laxmaiah Manchikanti, MD

OBSERVATIONAL STUDY

Long-Term Effectiveness of Repeated, Single-Day Intravenous Ketamine Infusions for Severe Arthritis: A Retrospective Cohort Study


Leonardo Kapural, Ishan Viradia, Sofia Korunda, Simran Dua, Neil Poddar, Carmen Bekavac, and Kunal Poddar




ASIPP is in collaboration with Curi Medical Liability Program




Since this malpractice insurance program officially launched in November 2018, ASIPP has signed up hundreds of providers with an average savings of 30%. This is professional liability insurance tailored to our specialty and will stand up for us and defend our practices. 

 

Curi is a full-service advisory firm that serves physicians and their practices. Their valued advice is grounded in your priorities and elevated in your outcomes. They are driven by a deep understanding of your specific circumstances in medicine, business, and life. To read a few important points to keep in mind about the program, including discounts, administrative defense, cyber coverage, aggressive claims handling, and complimentary risk management CME activities, visit our website.



IMPORTANT UPDATE

SPRINT no longer classified as PNT 



SPR is happy to announce an important update regarding Humana Medicare Advantage. As of May 1, Humana is now recognizing SPRINT as a PNS therapy. Previously, SPRINT was categorized as PNT (Percutaneous Nerve Stimulation), which allowed denials on the grounds that the therapy fell outside the NCD.


Additional details are as follows:

Payer: Humana Medicare Advantage (click here to view policy)

Policy Title: Peripheral Nerve Stimulators

Policy changes: SPRINT no longer misclassified as PNT and is now appropriately classified as PNS. Humana is applying the Noridian Medicare LCD criteria to ALL PNS devices – Including SPRINT PNS!

Effective Date: 5/1/2025


Click here to view a PDF of the official policy update.

 

Group Purchasing Organization Offer Better Pricing and Creates Added Value


ASIPP has formed a partnership with Henry Schein and PedsPal, a national GPO that has a successful history of negotiating better prices on medical supplies and creating value-added services for independent physicians. Working with MedAssets, PedsPal provides excellent pricing on products like contrast media that alleviate some of the financial pressures you experience today.



Learn More


For updated information concerning tariffs on products, click here.

 
 

ASIPP, Fedora Healthcare Solutions Partnership


ASIPP offers our members the benefit of a unique revenue cycle management/ billing service.



We have received a tremendous amount of interest in the ASIPP billing and coding program.




Click here to learn more about the negotiated rate for practices and more!

Like and Follow ASIPP® on Facebook, X, LinkedIn,

and YouTube for the most up-to-date news

related to you, your practice, and your patients!